Picture of Core Laboratories logo

CLB — Core Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsAdventurousSmall CapNeutral

Core Laboratories NV expected to post earnings of 19 cents a share - Earnings Preview

* Core Laboratories NV  CLB.N   CLB  is expected to show a rise
in quarterly revenue when it reports results on July 28. 
* The Amsterdam, Noord-holland-based company is expected to
report   a 3.1% increase in revenue to $119.28 million from
$115.74 million a year ago, according to the mean estimate from
6 analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Core Laboratories NV is
for earnings of 19 cents per share. For the same quarter last
year, the company reported earnings of 14 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 3 "strong buy" or "buy," 8
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Core
Laboratories NV is $33​, about 3.3% below​ its last closing
price of $34.08. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  0.12        0.13       0.15      Beat    15
 Dec. 31 2020  0.15        0.15       0.18      Beat    16.5
 Sep. 30 2020  0.13        0.15       0.16      Beat    9.2​
 Jun. 30 2020  0.10        0.10       0.14      Beat    42.1
 Mar.          0.31​       0.34       0.31      Missed  -7.5​
 31​ 2020​                                              
 Dec. 31 2019  0.37        0.37       0.38      Beat    2.2​
 Sep. 30 2019  0.49        0.49       0.50      Beat    2.8
 Jun. 30 2019  0.46        0.46       0.46      Met     0.5
 This summary was machine generated July 27 at 01:42 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Core Laboratories

See all news